Skip to main content
. 2023 Oct 24;15(11):2521. doi: 10.3390/pharmaceutics15112521

Figure 7.

Figure 7

Ex vivo permeation of RS from control in situ gel and optimized glycethosomal in situ gel formulation (G5).